- Benzinga•8 hours ago
Did you miss today's PreMarket Prep ? Here are some of the highlights from the show. Key Technical Levels The following are some of the stocks discussed on the show for which co-host Joel Elconin offered ...
- Motley Fool•8 hours ago
John Milligan's first year as Gilead's CEO hasn't been kind to shareholders.
- Benzinga•10 hours ago
On March 28, Galectin Therapeutics Inc (NASDAQ: GALT ) provided an update on the progress of its lead program , the Phase 2b trial of GR-MD-02 in Non-Alcoholic Steato-Hepatitis patients with cirrhosis ...
GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||67.50 x 100|
|Ask||67.71 x 500|
|Day's Range||67.10 - 67.78|
|52 Week Range||65.38 - 103.10|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.79|
|Dividend & Yield||2.08 (3.10%)|
|1y Target Est||N/A|